Aims and scope
Acupuncture in Medicine aims to promote the scientific understanding of acupuncture and related treatments by publishing scientific investigations of their effectiveness and modes of action as well as articles on their use in health services and clinical practice.
Acupuncture in Medicine is aimed at Western-trained physicians and other health professionals. The Western understanding of neurophysiology and anatomy is used to interpret the effects of acupuncture. The Journal uses the term ‘Western medical acupuncture’ and largely restricts its published articles to this Western approach. Evidence-based articles on traditional acupuncture (both clinical and theoretical) will, however, be considered. The editorial board welcomes scientific reports, systematic and general reviews, audits, case reports, descriptive and educational papers and other articles that may be of interest to readers.
AiM is owned by the British Medical Acupuncture Society and published by BMJ.
Journal Statistics 2016
Instant Reject Rate
Time from Submission to First Decision
Time from Acceptance to Online Publication
Index Medicus (Medline), Excerpta Medica (Embase), Science Citation Index Expanded (also known as SciSearch), Journal Citation Reports/Science Edition, Current Contents/Clinical Medicine, Scopus
For all contact information please refer to the Contact Us page.
Please refer to the Instructions for Authors
Rights and Permissions
Members of the British Medical Acupuncture Society receive Acupuncture in Medicine as a benefit of membership.
The BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting transparent, accurate reporting of research studies. BMJ is a sponsor of its activities.
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results.